Publications
| Title | Abstract | Year Filter | PMID(sorted descending) Filter |
|---|
| helicobacter pylori eradication in western australia using novel quadruple therapy combinations. | helicobacter pylori eradication rates with standard triple therapy are declining worldwide. the optimal management of h. pylori is evolving and new treatment combinations for antibiotic resistant h. pylori strains are required, especially for patients with penicillin allergy. | 2012 | 23072648 |
| tertiary paediatric refugee health clinic in western australia: analysis of the first 1026 children. | children account for approximately half of the humanitarian refugees currently resettled in australia. a multidisciplinary refugee health clinic (rhc) was established at the tertiary paediatric hospital in western australia to address burgeoning referrals of refugee children following voluntary post-resettlement health assessment. the aim of this study is to describe the epidemiology of common conditions in resettled paediatric refugees attending a tertiary multidisciplinary rhc. | 2012 | 22429646 |
| helicobacter pylori cytotoxin-associated gene-a antibodies do not predict complications or death in type 2 diabetes: the fremantle diabetes study. | there is cross-sectional evidence that caga antigen produced by helicobacter pylori is associated with coronary heart disease, stroke, atrial fibrillation (af) and microalbuminuria, but no large-scale longitudinal studies have been conducted in diabetic patients. we aimed to determine whether cytotoxin-associated gene-a (caga) seropositivity is independently associated with important vascular outcomes in type 2 diabetes. | 2010 | 20839379 |
| helicobacter pylori, helminth infections and growth: a cross-sectional study in a high prevalence population. | helicobacter pylori (h. pylori) infection is usually acquired in childhood and may adversely affect growth, although data are inconsistent. this study investigated growth parameters in a paediatric cohort with a high prevalence of h. pylori and helminth infection. | 2009 | 19191761 |
| antiplatelet therapy, helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the fremantle diabetes study. | to assess whether, based on its relationship with complications of peptic ulcer disease (pud), directed helicobacter pylori serological screening is justified in diabetic patients prior to commencement of antiplatelet therapy. | 2009 | 19125763 |
| helicobacter pylori--a nobel pursuit? | 2008 | 19018331 | |
| the epidemiology of helicobacter pylori infection in african refugee children resettled in australia. | to determine the prevalence and associated epidemiological features of helicobacter pylori infection in child refugees in western australia. | 2008 | 18928436 |
| marshall and warren: the nobel prize winners in medicine in 2005. | 2006 | 16649368 | |
| [the nobel prize in physiology or medicine for 2005 for the discovery of the stomach bacterium helicobacter pylori]. | this year, the nobel prize in physiology or medicine was awarded to the australian doctors marshall and warren for their discovery and further identification of the stomach bacterium helicobacter pylori. thanks to their confidence in their own observations, we are now able to cure people with peptic-ulcer disease and low-grade gastric lymphoma and are potentially able to prevent gastric cancer. | 2005 | 16425846 |
| spotlight on gastroenterology - the nobel prize laureates in physiology or medicine 2005: john robin warren and barry james marshall. | 2005 | 16293551 | |
| prevalence of helicobacter pylori in indigenous western australians: comparison between urban and remote rural populations. | 2005 | 15896188 | |
| prevalence of helicobacter pylori in indigenous western australians: comparison between urban and remote rural populations. | to determine and compare the prevalence of helicobacter pylori in an urban and a remote rural western australian indigenous community. | 2005 | 15748129 |
| a prospective study of infection and cardiovascular diseases: the busselton health study. | infectious agents might play a role in the aetiology of cardiovascular diseases. the aim was to determine the association of antibodies to implicated infectious agents with coronary heart disease (chd) and stroke in a population-based prospective study. | 2003 | 14555883 |
| antibiotic resistance in helicobacter pylori. | to describe antibiotic resistance patterns in helicobacter pylori. | 2000 | 11194734 |
| short duration therapy for helicobacter pylori in western australia: the impact of metronidazole resistance. | limited australian data are available on either short duration therapy for helicobacter pylori infection, or the impact of metronidazole resistance on the outcome of treatment. | 1998 | 9544380 |
| barry marshall and the resurrection of johannes fibiger. | 1996 | 8814125 | |
| helicobacter pylori: 10th anniversary of its culture in april 1982. | 1993 | 8472974 | |
| when is helicobacter pylori infection acquired? | cross sectional surveys have shown an increasing prevalence of helicobacter pylori (h pylori) infection with increasing age in western populations. the aim of this study was to examine the pattern of acquisition of h pylori infection over a 21 year period in a group of 141 adults who had blood samples and serum stored in 1969, 1978, and 1990. a prevalence of h pylori antibody of 39% in 1969 serum samples, 40.9% in 1978, and 34.8% in 1990 was found when assessed by an enzyme linked immunosorbent ... | 1993 | 8282255 |
| how helicobacter pylori acquired its name, and how it overcomes gastric defence mechanisms. | at royal perth hospital, western australia in april 1982, spiral bacteria were first cultured from a gastric biopsy specimen. several important taxonomic features were identified which indicated that these bacteria represented a new genus. in october 1989 the new genus name helicobacter was published. helicobacter pylori overcomes gastric defence mechanisms by means of its powerful urease enzyme, by its spiral shape allowing it to penetrate mucus, by adherence to the gastric mucosa and by variou ... | 1994 | 7881010 |
| the 14c-urea breath-test for the detection of gastric campylobacter pylori infection. | a breath-test has been developed for the detection of gastric infection with campylobacter pylori. urea that is labelled with carbon 14 is administered to a fasting patient and the patient's breath is sampled for radioactivity over the following 30 minutes. if c. pylori is present in the patient's stomach, urease activity causes hydrolysis of the urea and the 14c is absorbed as carbon dioxide. this carbon dioxide enters the patient's bicarbonate pool and eventually is excreted in the breath. the ... | 1989 | 2593958 |